Drug Patent List
First Filer Exclusivity TimelineNew
Newsletter
Weekly Digest

Pharsight

Methimazole Oral Solution Patent Expiration

Methimazole Oral Solution Petitions

Details of Methimazole Oral Solution's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
Felix Pharmaceuticals Pvt. Ltd. Approved 20 Jan, 2022 The proposed change is for an oral solution ; the RLNAD is approved as unscored, coated tablets in 2.5 mg and 5 mg tablet strengths.
Norbrook Laboratories, Ltd. Approved 12 Oct, 2018 The proposed change is for an oral solution ; the RLNAD is approved as coated tablets in 2.5 mg and 5 mg tablet strengths.

About Methimazole Oral Solution

Methimazole Oral Solution is a drug owned by FELIX PHARMACEUTICALS PVT. LTD. Methimazole Oral Solution uses Methimazole as the active ingredient.

Active Ingredient:

Methimazole Oral Solution uses Methimazole as the active ingredient. Check out other Drugs and Companies using Methimazole ingredient.